Ethypharm

Ethypharm announces the commercial launch in the US of a new product using its Flashtab® technology. Tramadol Flashtab® is available since end of May, 2010. This new commercial launch confirms Ethypharm’s strong commitment to increase its presence on the North American market.

Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon’s global excipient product offerings in the pharmaceutical and nutritional markets.

Ethypharm announces the cession of its subsidiary NP PHARM to COLORCON, a company dedicated to the development, supply and technical support of formulated coatings and excipients for the pharmaceutical industry.

Ethypharm announces the cession of its R&D center in Laval (Montreal), Canada. The R&D center of Laval, certified by both Canadian and American Health Authorities, was dedicated to the development of oral modified release form medicines and employed 31 people.